Click on image to view larger version.

Figure 3 Changes in Plasma Osmolality

Mean change from baseline in plasma osmolality (OSM) in the 4 treatment groups. A significant increase was observed in all of the tolvaptan dosing groups (p < 0.0005 for all tolvaptan groups vs. placebo at 4 h and later).